Dividend Yield
Search documents
How To Earn $500 A Month From Campbell's Stock Ahead Of Q3 Earnings
Benzinga· 2025-05-30 12:22
Earnings Report - Campbell's Company (CPB) is set to release its third-quarter earnings results on June 2, with analysts expecting earnings of 66 cents per share, a decrease from 75 cents per share in the same period last year [1] - The company projects quarterly revenue of $2.43 billion, an increase from $2.37 billion reported in the previous year [1] Analyst Ratings - Piper Sandler analyst Michael Lavery has maintained an Overweight rating on Campbell's, while lowering the price target from $45 to $42 [2] Dividend Information - Campbell's offers an annual dividend yield of 4.57%, translating to a quarterly dividend of 39 cents per share, or $1.56 annually [2] - To generate $500 monthly or $6,000 annually from dividends, an investment of approximately $131,418 or around 3,846 shares is required. For $100 monthly or $1,200 annually, an investment of $26,277 or around 769 shares is needed [2] Dividend Yield Calculation - The dividend yield is calculated by dividing the annual dividend payment by the stock's current price, which can fluctuate based on changes in stock price and dividend payments [3][4] - For example, if a stock pays an annual dividend of $2 and is priced at $50, the yield is 4%. If the price rises to $60, the yield drops to 3.33%, and if it falls to $40, the yield increases to 5% [3] Stock Performance - Shares of Campbell's gained 1.1%, closing at $34.17 on Thursday [4]
TriplePoint Venture Growth: 18% Dividend Yield Is A Red Flag (Downgrade)
Seeking Alpha· 2025-05-29 16:37
Core Insights - TriplePoint Venture Growth BDC (NYSE: TPVG) reduced its dividend in Q3 2024, indicating potential ongoing challenges in maintaining dividend payouts [1] Group 1: Dividend Performance - The company has shown weakening dividend payout metrics since the dividend cut, raising concerns about the sustainability of even the reduced dividend [1]
Investar (ISTR) Could Be a Great Choice
ZACKS· 2025-05-28 16:50
Company Overview - Investar (ISTR) is headquartered in Baton Rouge and has experienced a price change of -12.3% this year [3] - The company currently pays a dividend of $0.1 per share, resulting in a dividend yield of 2.18%, which is lower than the Banks - Southeast industry's yield of 2.4% and higher than the S&P 500's yield of 1.56% [3] Dividend Performance - Investar's current annualized dividend of $0.42 has increased by 2.4% from the previous year [4] - Over the past five years, Investar has raised its dividend five times, achieving an average annual increase of 12.44% [4] - The company's current payout ratio is 20%, indicating that it pays out 20% of its trailing 12-month earnings per share as dividends [4] Earnings Growth Expectations - For the fiscal year, Investar anticipates solid earnings growth, with the Zacks Consensus Estimate for 2025 projected at $1.95 per share, reflecting a year-over-year growth rate of 3.17% [5] Investment Considerations - Investar is considered a compelling investment opportunity due to its strong dividend profile and current Zacks Rank of 3 (Hold) [7]
Why Ventas (VTR) is a Great Dividend Stock Right Now
ZACKS· 2025-05-28 16:50
Company Overview - Ventas (VTR) is a Chicago-based real estate investment trust (REIT) focused on seniors housing, with a year-to-date price change of 10.46% [3] - The company currently pays a dividend of $0.48 per share, resulting in a dividend yield of 2.95%, which is lower than the industry average of 5.19% and the S&P 500's yield of 1.56% [3] Dividend Performance - Ventas has an annualized dividend of $1.92, reflecting a 6.7% increase from the previous year [4] - Over the past five years, the company has increased its dividend once on a year-over-year basis, with an average annual increase of 0.37% [4] - The current payout ratio for Ventas is 59%, indicating that it pays out 59% of its trailing 12-month earnings per share as dividends [4] Earnings Outlook - For the fiscal year 2025, the Zacks Consensus Estimate projects earnings of $3.44 per share, representing a 7.84% increase from the previous year [5] Investment Considerations - Dividends are favored by investors for various reasons, including tax advantages and risk reduction in portfolios [6] - High-yielding stocks may face challenges during periods of rising interest rates, but Ventas is considered a compelling investment opportunity due to its strong dividend profile [7] - The stock currently holds a Zacks Rank of 3 (Hold), indicating a neutral outlook [7]
How To Earn $500 A Month From Macy's Stock Ahead Of Q1 Earnings
Benzinga· 2025-05-27 12:40
Macy’s, Inc. M will release its first-quarter financial results before the opening bell on Wednesday, May 28.Analysts expect the company to report quarterly earnings at 14 cents per share, down from 27 cents per share in the year-ago period and quarterly revenue of $4.5 billion, compared to $4.85 billion a year earlier, according to data from Benzinga Pro.On May 6, Morgan Stanley analyst Alex Straton maintained Macy’s with an Equal-Weight rating and lowered the price target from $14 to $12.With the recent b ...
Univest (UVSP) Could Be a Great Choice
ZACKS· 2025-05-26 16:51
Company Overview - Univest is headquartered in Souderton and operates as a holding company for Univest Bank and Trust Co. [3] - The stock has experienced a price change of -0.44% year-to-date [3]. Dividend Information - Univest currently pays a dividend of $0.22 per share, resulting in a dividend yield of 3%, which is higher than the Northeast banking industry's yield of 2.82% and the S&P 500's yield of 1.6% [3]. - The annualized dividend of $0.88 represents a 4.8% increase from the previous year [4]. - Over the past five years, Univest has increased its dividend once on a year-over-year basis, with an average annual increase of 1.42% [4]. - The current payout ratio is 32%, indicating that the company paid out 32% of its trailing 12-month earnings per share as dividends [4]. Earnings Expectations - The Zacks Consensus Estimate for Univest's earnings in 2025 is projected at $2.63 per share, reflecting a year-over-year growth rate of 5.20% [5]. Investment Considerations - Univest is considered a compelling investment opportunity due to its strong dividend profile and current Zacks Rank of 3 (Hold) [7].
Intesa Sanpaolo SpA (ISNPY) is a Top Dividend Stock Right Now: Should You Buy?
ZACKS· 2025-05-26 16:51
Company Overview - Intesa Sanpaolo SpA (ISNPY) is headquartered in Turin and has experienced a price change of 34.53% this year [3] - The company currently pays a dividend of $0.84 per share, resulting in a dividend yield of 5.16%, which is significantly higher than the Banks - Foreign industry's yield of 3.8% and the S&P 500's yield of 1.6% [3] Dividend Performance - The annualized dividend of Intesa Sanpaolo is $1.68, reflecting a 13.6% increase from the previous year [4] - Over the past five years, the company has increased its dividend three times year-over-year, with an average annual increase of 40.86% [4] - The current payout ratio is 49%, indicating that the company pays out 49% of its trailing 12-month earnings per share as dividends [4] Earnings Expectations - The Zacks Consensus Estimate for earnings in 2025 is $3.41 per share, with an expected increase of 9.29% from the previous year [5] Investment Appeal - Intesa Sanpaolo is viewed as an attractive dividend investment and a compelling opportunity, holding a Zacks Rank of 1 (Strong Buy) [7]
Mensch und Maschine Software Is Cheaply Valued And Provides Investors With A Record Dividend Yield
Seeking Alpha· 2025-05-26 13:34
Core Viewpoint - Mensch und Maschine Software SE (OTC:MSHHF) is highlighted as a significant stock within a diversified retirement portfolio, despite its market capitalization being under $1 billion, indicating it may not be widely recognized by investors [1]. Company Summary - The company is characterized as one of the largest stocks in a broadly diversified retirement portfolio, suggesting a strong position within its sector [1]. - The market cap of Mensch und Maschine Software SE is noted to be less than $1 billion, which may contribute to its lower visibility among investors [1]. Investor Perspective - The article reflects a long-term investment strategy, emphasizing the importance of conducting thorough research and due diligence before making investment decisions [1]. - The author expresses a personal beneficial long position in the shares of MSHHF, indicating confidence in the company's future performance [1].
Pfizer's 7.5% Dividend: Income Haven or House of Cards?
MarketBeat· 2025-05-23 19:21
Core Viewpoint - Pfizer's high dividend yield of 7.5% attracts income-seeking investors, but underlying concerns about future growth and financial stability exist due to revenue declines and patent expirations [1][2][13]. Dividend Overview - Pfizer currently pays an annual dividend of $1.72 per share, translating to a quarterly payment of $0.43 per share, resulting in a dividend yield of 7.5% as of May 22, 2025 [2][3]. - The company has a strong track record of increasing dividends for 16 consecutive years, appealing to investors seeking reliable income [4]. Financial Metrics - Pfizer's annualized 3-year dividend growth stands at 2.50%, with a dividend payout ratio of 124.64% based on trailing earnings, indicating that dividends exceed earnings [4][6]. - The dividend payout consumes approximately 47.69% of its cash flow, suggesting a more sustainable dividend based on cash generation [5]. Revenue Challenges - In Q1 2025, Pfizer's total revenues decreased by 8% year-over-year to $13.7 billion, primarily due to a 75% drop in Paxlovid sales as COVID-19 demand normalized [7]. - The company faces a significant revenue loss of $17-$18 billion annually between 2026 and 2028 due to the impending loss of exclusivity for key drugs like Eliquis and Prevnar [8]. Strategic Initiatives - Pfizer is pursuing a strategy focused on pipeline rejuvenation, particularly in oncology, highlighted by the $43 billion acquisition of Seagen in March 2023, which contributed $3.4 billion to revenue in FY 2024 [9]. - The company has entered a licensing agreement with 3SBio, Inc. for SSGJ-707, with an upfront payment of $1.25 billion, potentially worth up to $6 billion, aiming to launch eight new cancer medicines by 2030 [10]. Pipeline Developments - Positive developments in the oncology pipeline include FDA approval for Adcetris in large B-cell lymphoma and promising clinical data for Padcev in urothelial cancer [11]. - The Abrysvo RSV vaccine has seen expanded recommendations, potentially increasing market reach, although setbacks occurred with the discontinuation of the oral GLP-1 candidate danuglipron [12]. Investment Outlook - Pfizer's stock forecast indicates a 12-month price target of $29.17, representing a 25.08% upside, with a Moderate Buy rating based on 15 analyst ratings [13]. - The current high dividend yield is attractive, but the company faces significant operational challenges and uncertainties regarding future revenue growth [14][15].
UPS: The Near 7% Yield Is Worth A Look, Shares Near Key Support
Seeking Alpha· 2025-05-23 18:50
Group 1 - UPS ranks No. 11 in the S&P 500 in terms of dividend yield with a forward rate of 6.84% as of May 21, 2025 [1] - The article emphasizes the importance of creating engaging financial content that is relevant and accessible to everyday investors [1] - The focus is on analyzing various asset classes including stocks, bonds, commodities, currencies, and crypto, highlighting macro drivers that influence market conditions [1] Group 2 - The article does not provide any specific investment recommendations or advice regarding the suitability of investments for particular investors [2][3] - It clarifies that past performance is not indicative of future results, emphasizing the need for caution in investment decisions [3] - The authors of the article are not licensed securities dealers or investment advisers, indicating a lack of formal regulatory oversight [3]